General Information
BounceWatch is an independent company data service, not affiliated with Wugen. To contact Wugen, visit wugen.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Wugen compare?
A PDF of Wugen and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Wugen soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Wugen on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United States Market
Biotechnology
About Wugen
Business keywords: cell therapy, off-the-shelf, NK cells, CAR-T cells, cancer, Moneta platform, genomic engineering, immuno-oncology, AML, solid tumors, clinical-stage, St. Louis, San Diego, memory NK cells
Funding Rounds & Investors (5)
View AllWugen Alternatives & Competitors
View All Alternatives‘Off-the-Shelf’ Curative Cell Therapies
Pioneering thymus-empowered T-cell platform to fight cancer and infection
Developing next-generation TIL-based therapies to treat and cure solid tumors.
FAQ About Wugen
Source: BounceWatch company record for Wugen, https://bouncewatch.com/company/wugen, updated 9 June 2026. When citing, please name BounceWatch and link this page.